Increased levels of glutamate in brains from patients with mood disorders.
about
Neuroinflammation and psychiatric illnessGlycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male ratsTowards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersBipolar Disorder: Role of Inflammation and the Development of Disease BiomarkersInnate and adaptive immunity in the development of depression: An update on current knowledge and technological advancesManagement of bipolar depression with lamotrigine: an antiepileptic mood stabilizerZinc in the Glutamatergic Theory of DepressionAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueReview of pharmacological treatment in mood disorders and future directions for drug development.Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceCytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaisePeripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric researchNeurobiology of chronic mild stress: parallels to major depressionA brief history of the development of antidepressant drugs: from monoamines to glutamatePsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorLong-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of miceDeletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviorsMetabotropic glutamate receptor 3 is associated with heroin dependence but not depression or schizophrenia in a Chinese populationValproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylationConceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depressionNeonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood: clinical rescue by d-serineThe absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice.Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.Brain Rewarding Stimulation Reduces Extracellular Glutamate Through Glial Modulation in Medial Prefrontal Cortex of RatsChronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.Mood-stabilizers target the brain arachidonic acid cascade.Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression.Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patientsIncreased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.Brain glutamatergic characteristics of pediatric offspring of parents with bipolar disorder.Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder.Presynaptic glutamatergic dysfunction in bipolar disorderChronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscalingAltered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorderIntegrated neurobiology of bipolar disorder.Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure.Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disordersAltered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjectsMultiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach
P2860
Q21245244-41494B59-FF34-4226-ADEB-10FF47986C18Q24629780-4EA0F6B9-C006-48C7-BF70-654220D3BC2BQ24632936-DD2B0B2D-2781-4472-AD2C-2F6452BFFE2FQ26772017-DE0D462E-A665-45E5-BDEF-08412DCB027FQ26775316-E914AAFD-A68C-4224-8452-34249C6BE83DQ26777966-CB4905E6-0222-426E-AC4F-45F7B75BA64DQ26786214-20B2AFBA-74F2-4323-89D2-064ED196B234Q26827833-D9ED40F7-14C0-407A-AE85-1E02BC52A58DQ26853509-C34C0BEF-C477-4A9A-9C54-16525863C87EQ26999061-9DF03CBC-6D3B-4F55-BE82-5177E2E1D002Q27001628-483FBCB8-0E32-480D-A6F7-CB249BAAAD3DQ27012892-3730718D-2A05-433B-9F80-D076AF1F376BQ27026698-18DA294A-9945-4E51-9DE3-25004C8B228DQ27028050-758FA1D8-D1EB-45F8-801D-F450544154DDQ27694728-BA0CE3BE-9884-44BC-A5F9-F4FBD88C19AEQ28485938-904B62A3-EA99-460F-AF4E-AB994CDC3185Q28512821-99F46F1A-6D24-4EC4-AD5C-4BC52C52582EQ28539376-4F0C7F44-E230-426B-857B-82578768E74FQ28572236-AFA1E1E1-65B5-4E9C-9CB6-2073204ADAF9Q28830670-5A887EC0-891E-41DE-BAE8-1407B2D4A68DQ30455182-3D7FCC32-1D13-4FA4-8D33-A9CC29EE73E7Q30540124-C290608F-2B21-47B7-BED8-2B20B39B00BAQ30572014-FD5FC509-94B6-4DF3-904D-3DF316458D06Q30756186-D84350AE-67A4-4537-96AD-9DD4C2ABA347Q30906677-B9EEEF15-D38D-4C17-9FF6-3B80D9C42AFEQ33611796-6CB30326-4E97-47C2-99DF-CCB25609607AQ33671302-4BC17173-F5F5-4211-BD25-2DEF8D55E39CQ33678656-ACB85DD9-AC01-465B-B401-942BE46F22F3Q33718794-BFE981E3-047D-40BE-8ED0-03FD0B339832Q33751063-84CE5055-3B16-4B39-8AEA-CDFE48B3E4DAQ33838237-EE2EE585-B15D-4206-8309-80D3386EEE36Q33846348-7854AD6D-B1F6-45BA-8379-0C428A699615Q33857903-32F0FD21-B8C5-4C54-A8F9-4206EE77E2C8Q33879254-D60BA7E0-BA7E-42EA-8C6D-EAB2ECBBDECFQ33884852-D1C2DE43-F799-4E4A-B4D6-4AAAF3733813Q34080310-0104D2B5-BEEC-4BD0-8049-B75F1EB0B608Q34129846-A756B492-ACC6-4335-885C-951948AD549FQ34204211-1E629FD3-3525-43C4-9B03-B02C24FDF7B2Q34254887-6A09BF3E-CDCB-4E84-8EFF-6DAF768B623CQ34268501-89F4F89B-1A7C-4EB1-904A-CD90ABFDB414
P2860
Increased levels of glutamate in brains from patients with mood disorders.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Increased levels of glutamate in brains from patients with mood disorders.
@en
Increased levels of glutamate in brains from patients with mood disorders.
@nl
type
label
Increased levels of glutamate in brains from patients with mood disorders.
@en
Increased levels of glutamate in brains from patients with mood disorders.
@nl
prefLabel
Increased levels of glutamate in brains from patients with mood disorders.
@en
Increased levels of glutamate in brains from patients with mood disorders.
@nl
P1476
Increased levels of glutamate in brains from patients with mood disorders
@en
P2093
Akira Sawa
Masaomi Iyo
P304
P356
10.1016/J.BIOPSYCH.2007.03.017
P407
P50
P577
2007-06-15T00:00:00Z